The Stockholm Stock Exchange is seeing only slight price movements at midday on Tuesday, the final trading day before the Christmas holidays. In the news flow, Orexo is climbing sharply following a rights sale. The trend is similar across major European stock markets.

At around 12:50 PM, the OMXS30 index was up 0.12 percent at 2,848.49. Shares worth approximately SEK 4.6 billion had been traded on the Stockholm Exchange.

Among the exchange's larger industrial sectors, real estate performed best with a gain of 0.4 percent. On the other hand, energy was at the bottom, down 0.3 percent.

Among the leading stocks included in the OMXS30 index, Saab B rose by 2.7 percent while Telia was up 1.4 percent. Epiroc A performed the worst, down 0.6 percent, while Ericsson B slipped 0.5 percent.

Defense company Saab secured an order for ground combat weapons from Lithuania worth SEK 1.3 billion.

Telecom operator Telia has received approval from the Swedish Competition Authority for its takeover bid for Bredband2. With this, Telia has now obtained all necessary regulatory approvals for the deal, and the condition regarding approvals has been fulfilled. There had previously been some market uncertainty about whether the Competition Authority would allow the deal. Bredband2 rose 10 percent to SEK 3.22 and is now trading close to the offer price of SEK 3.25.

Pharmaceutical company Orexo has signed an agreement to sell the U.S. rights to Zubsolv for USD 91 million, equivalent to SEK 845 million. The buyer is Dexcel Pharma USA. The deal was positively received and the share climbed 14 percent.

Energy company Orrön Energy has signed an agreement with Germany's Gülermak to sell three solar energy projects in Germany for up to EUR 14 million. The projects are under development and have a combined expected installed capacity of 234 megawatts. The share increased by 1.6 percent.

Real estate company Corem Property is launching a share buyback program. The company may, until the annual general meeting in spring 2026, buy back up to 10 percent of its shares. The B share rose by 5.1 percent.

Investment company Flat Capital's portfolio company Defensor announced that its subsidiaries Armatech and SAFE4U are expected to exceed the previous forecast for the 2025 calendar year. Revenue is now estimated to be 20 percent higher than the previous forecast of SEK 410 million, while operating profit is expected to exceed the forecast of SEK 100 million by 10 percent. The share rose by 0.7 percent.

Among smaller companies, industrial technology firm Cell Impact's board delivered a disappointing Christmas present to shareholders in the form of a rights issue of SEK 38 million. The share fell by 25 percent.

Real estate company Hufvudstaden declined by 1.1 percent. Kepler Cheuvreux downgraded its recommendation to "hold" from "buy."